A Mobile Intervention on Values in Chronic Pain Patients.

October 5, 2022 updated by: Jenny Riecke, Philipps University Marburg Medical Center
The study aims to test a mobile intervention on values and goals in chronic pain patients. The cognitive behavioral intervention is a 10-day course in which participants complete a brief intervention each day (about 10-20 minutes a day). The content of the intervention includes the definition of values; development of individualized values and personal value-oriented goals; and implementation of personal goals in every day life. To assess the effectiveness of the intervention, we use a multiple baseline single case design. Baseline measurements will be assessed daily between 10 and 17 days (the exact number will be randomized). Daily measurements will continue during the intervention. After the intervention, another post measurement will be collected.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hessen
      • Marburg, Hessen, Germany, 35032
        • University of Marburg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Chronic, non-tumor related back pain (pain for at least 6 months)
  • Ownership of a smartphone
  • Numeric Rating Scale for pain result of ≥ 4

Exclusion Criteria:

  • High cognitive impairment (e.g., intellectual disability)
  • Currently in psychotherapeutic treatment
  • Initiation of pain-focused treatment during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mobile based values intervention for people with chronic pain
The protocol consists of 10 daily sessions, 10-20 Minutes each. After each session participants will complete daily measures. Participants will learn about values and a values based life. Further they will identify their own values and are encouraged to set a goal to pursue those values. Based on this, barriers to achieving goals are explained and a corresponding commitment will be made.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain intensity
Time Frame: Pain intensity is assessed daily from baseline to the end of treatment (resulting in 20-27 measuring time points)
Numerical Pain Rating Scale (NPRS) Minimum value: 0; Maximum value: 10 (higher scores indicate higher pain intensity)
Pain intensity is assessed daily from baseline to the end of treatment (resulting in 20-27 measuring time points)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in psychological well-being
Time Frame: Psychological well-being is assessed daily from baseline to the end of treatment (resulting in 20-27 measuring time points)
The five-item WHO Well-Being Index (WHO-5) Minimum value: 0; Maximum value 10 (range is adapted for the study; higher scores indicate higher psychological well-being)
Psychological well-being is assessed daily from baseline to the end of treatment (resulting in 20-27 measuring time points)
Change in chronic pain acceptance
Time Frame: Chronic Pain Acceptance is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
Chronic Pain Acceptance Questionnaire (CPAQ) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher pain acceptance)
Chronic Pain Acceptance is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
Change in engaged living
Time Frame: Engaged Living is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
Engaged Living Scale (ELS) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher engaged living)
Engaged Living is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
Change in pain catastrophizing
Time Frame: Pain Catastrophizing is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
Pain Catastrophizing Scale (PCS) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher catastrophizing)
Pain Catastrophizing is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
Change in psychological flexibility
Time Frame: Psychological Flexibility is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
Acceptance and Action Questionnaire 2 (AAQ-2) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate lower psychological flexibility)
Psychological Flexibility is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
Change in self-efficacy
Time Frame: Self-efficacy is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)
Pain Self-efficacy Questionnaire (PSEQ) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher self-efficacy)
Self-efficacy is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Winfried Rief, PhD, Philipps University Marburg Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2022

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

May 31, 2022

Study Registration Dates

First Submitted

December 21, 2021

First Submitted That Met QC Criteria

January 12, 2022

First Posted (Actual)

January 25, 2022

Study Record Updates

Last Update Posted (Actual)

October 7, 2022

Last Update Submitted That Met QC Criteria

October 5, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SCA0222

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

Data can be shared upon request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain Syndrome

Clinical Trials on Mobile intervention on values and goals in patients with chronic pain.

3
Subscribe